Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INTELGENX TECHNOLOGIES CORP.

(IGXT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

IntelGenx Brief: Says Initiated Arbitration Proceeding Against Tilray Related to Alleged Breach of Worldwide Cannabis-Infused VersaFilm Agreement

12/08/2021 | 08:09am EST


ę MT Newswires 2021
All news about INTELGENX TECHNOLOGIES CORP.
09:22aFirst Patient Dosed in IntelGenx's Resumed 'BUENA' Montelukast VersaFilm Phase 2a Clini..
AQ
01/20IntelGenx Says First Patient Dosed in BUENA Phase 2a Clinical Trial in Patients with Mi..
MT
01/20First Patient Dosed in IntelGenx's Resumed ‘BUENA' Montelukast VersaFilm« Phase 2..
AQ
01/20First Patient Dosed in IntelGenx Technologies Corp. Resumed ‘Buena’ Monteluka..
CI
2021IntelGenx Initiates Arbitration Proceeding Against Tilray Related to an Alleged Breach ..
AQ
2021INTELGENX TECHNOLOGIES : Initiates Arbitration Proceeding Against Tilray« Related to an Al..
PU
2021INTELGENX TECHNOLOGIES CORP. : Other Events (form 8-K)
AQ
2021IntelGenx Initiates Arbitration Proceeding Against Tilray Over Alleged Breach of Cannab..
MT
2021INTELGENX BRIEF : Says Initiated Arbitration Proceeding Against Tilray Related to Alleged ..
MT
2021IntelGenx Initiates Arbitration Proceeding Against Tilray« Related to an Alleged Breach..
AQ
More news
Financials (USD)
Sales 2021 10,3 M - -
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 50,5 M 50,5 M -
Capi. / Sales 2021 4,90x
Capi. / Sales 2022 2,75x
Nbr of Employees 50
Free-Float 74,9%
Chart INTELGENX TECHNOLOGIES CORP.
Duration : Period :
IntelGenx Technologies Corp. Technical Analysis Chart | IGXT | US45822R1014 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 0,33 $
Average target price 0,82 $
Spread / Average Target 151%
Managers and Directors
Horst G. Zerbe Chairman & Chief Executive Officer
AndrÚ Godin President & Chief Financial Officer
Nadine Paiement Vice President-Research & Development
Rodolphe Obeid Chief Operating Officer
Bernd Josef Melchers Independent Director